[Combined chemohormonal therapy for metastatic hormone-sensitive prostate cancer : Effectiveness and update as a joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)]

MeSH terms

• Androgen Antagonists / standards
• Androgen Antagonists / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
• Antineoplastic Combined Chemotherapy Protocols / standards
• Carcinoma / drug therapy*
• Carcinoma / secondary*
• Evidence-Based Medicine
• Germany
• Humans
• Male
• Medical Oncology / standards*
• Practice Guidelines as Topic
• Prostatic Neoplasms / drug therapy*
• Treatment Outcome
• Urology / standards